301207 華蘭疫苗
按盤價 
21.100 -0.850 (-3.872%)
21.100 -0.850 (-3.872%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.264 | 3.348 | 14.626 | 12.514 | 24.863 |
| 總資產報酬率 ROA (%) | 1.800 | 2.649 | 11.412 | 8.960 | 15.199 |
| 投入資產回報率 ROIC (%) | 2.195 | 3.181 | 13.868 | 11.346 | 21.417 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.994 | 81.153 | 88.089 | 88.089 | 87.935 |
| 營業利潤率 (%) | 17.290 | 19.051 | 41.904 | 32.462 | 38.637 |
| 息稅前利潤/營業總收入 (%) | 16.952 | 18.397 | 41.564 | 31.989 | 39.018 |
| 淨利潤/營業總收入 (%) | 16.416 | 18.222 | 35.677 | 28.463 | 33.936 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 35.197 | 77.619 | 99.640 | 117.066 | 113.125 |
| 價值變動淨收益/利潤總額(%) | 51.307 | 46.784 | 10.942 | 12.290 | 5.385 |
| 營業外收支淨額/利潤總額(%) | -1.252 | -0.145 | -0.315 | -0.535 | -0.174 | 償債能力分析 |
| 流動比率 (X) | 3.264 | 3.399 | 3.101 | 2.728 | 1.513 |
| 速動比率 (X) | 3.080 | 3.256 | 2.998 | 2.619 | 1.448 |
| 資產負債率 (%) | 20.956 | 20.073 | 21.666 | 22.316 | 37.921 |
| 帶息債務/全部投入資本 (%) | 0.019 | 4.443 | 4.124 | 4.853 | 14.595 |
| 股東權益/帶息債務 (%) | 530,761.076 | 2,134.345 | 2,307.421 | 1,945.534 | 576.286 |
| 股東權益/負債合計 (%) | 377.184 | 398.192 | 361.563 | 348.118 | 163.703 |
| 利息保障倍數 (X) | -137.350 | -29.372 | -199.512 | -106.640 | 87.031 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 466.555 | 547.106 | 282.792 | 318.997 | 292.040 |
| 存貨周轉天數 (天) | 348.195 | 323.749 | 213.562 | 227.277 | 124.487 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
